CALR mutations and JAK2/myeloproliferative leukemia protein (MPL) mutations are almost completely mutually exclusive in MPN patients, suggesting that mutant CALR also activates cytokine signalling. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.